Meanwhile, consider extra support like SymptoGuard designed to help GLP-1 users feel more like themselves again
In contrast, diabetes treatments focus on controlling blood sugar and often use lower doses or doses given at different times
Studies in lean and obese subjects and during short-term fasting.Sinha MK, Opentanova I, Ohannesian JP, Kolaczynski JW, Heiman ML, Hale J, Becker GW, Bowsher RR, Stephens TW, Caro JF
Instead of pushing every patient to the maximum dose, clinicians may maintain individuals at lower doses that still produce meaningful metabolic effects
Novo Nordisk Patients Seeking Upgrade CagriSema Patients already on semaglutide (Wegovy) who need greater weight loss can potentially upgrade to CagriSema within the Novo Nordisk ecosystem once approved, leveraging the same GLP-1 component plus added amylin agonism
The focus of yogic diets on nutrient-dense, plant-based foods, along with the prevention of overeating, can aid in weight management, an important aspect of T2D management
